May 9, 2017 /

Results from Phase I/II HOPE Clinical Trial of CAP-1002 (April 2017)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Results from Phase I/II HOPE Clinical Trial of CAP-1002 (April 2017)

Parent Project Muscular Dystrophy, Coalition Duchenne, and Capricor hosted a webinar on April 28, 2017 to hear a community update on the six-month results from Capricor’s randomized Phase I/II HOPE Clinical Trial of CAP-1002 (allogeneic cardiosphere-derived cells), an investigational candidate for the treatment of Duchenne.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo